Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Schafer

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2000
Rapid development of tamoxifen-stimulated mutant p53 breast tumors (T47D) in athymic miceJ M Schafer, E S Lee, R M O'Regan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Effects of the new selective estrogen receptor modulator LY353381.HCl (Arzoxifene) on human endometrial cancer growth in athymic miceR C Dardes, D Bentrem, R M O'Regan, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|August 29, 2019
Detection of splenic microabscesses with ultrasound as a marker for extrapulmonary tuberculosis in patients with HIV: A systematic reviewJ M Schafer, J Welwarth, V Novack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
Cross-resistance of triphenylethylene-type antiestrogens but not ICI 182,780 in tamoxifen-stimulated breast tumors grown in athymic miceE S Lee, J M Schafer, K Yao, et al.
Cancer Research|September 18, 2001
Molecular classification of estrogensV C Jordan, J M Schafer, A S Levenson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Analysis of cross-resistance of the selective estrogen receptor modulators arzoxifene (LY353381) and LY117018 in tamoxifen-stimulated breast cancer xenograftsJ M Schafer, E S Lee, R C Dardes, et al.
Oncogene|January 11, 2011
c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptaseR Szabo, A L Rasmussen, A B Moyer, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2000
Rapid development of tamoxifen-stimulated mutant p53 breast tumors (T47D) in athymic miceJ M Schafer, E S Lee, R M O'Regan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Effects of the new selective estrogen receptor modulator LY353381.HCl (Arzoxifene) on human endometrial cancer growth in athymic miceR C Dardes, D Bentrem, R M O'Regan, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|August 29, 2019
Detection of splenic microabscesses with ultrasound as a marker for extrapulmonary tuberculosis in patients with HIV: A systematic reviewJ M Schafer, J Welwarth, V Novack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
Cross-resistance of triphenylethylene-type antiestrogens but not ICI 182,780 in tamoxifen-stimulated breast tumors grown in athymic miceE S Lee, J M Schafer, K Yao, et al.
Cancer Research|September 18, 2001
Molecular classification of estrogensV C Jordan, J M Schafer, A S Levenson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Analysis of cross-resistance of the selective estrogen receptor modulators arzoxifene (LY353381) and LY117018 in tamoxifen-stimulated breast cancer xenograftsJ M Schafer, E S Lee, R C Dardes, et al.
Oncogene|January 11, 2011
c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptaseR Szabo, A L Rasmussen, A B Moyer, et al.
Pageof 1